These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9707312)

  • 1. In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.
    Alarcón T; Domingo D; Sánchez I; Sanz JC; Martínez MJ; López-Brea M
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):275-7. PubMed ID: 9707312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine.
    van Herwaarden MA; Samsom M; van Nispen CH; Mulder PG; Smout AJ
    Aliment Pharmacol Ther; 1999 Jun; 13(6):731-40. PubMed ID: 10383501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection.
    Bravo LE; Realpe JL; Campo C; Mera R; Correa P
    Am J Gastroenterol; 1999 Sep; 94(9):2380-3. PubMed ID: 10483995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro.
    Vogt K; Hahn H
    Arzneimittelforschung; 1998 Jun; 48(6):694-7. PubMed ID: 9689430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates.
    Alarcón T; Domingo D; Prieto N; López-Brea M
    Rev Esp Quimioter; 1999 Mar; 12(1):64-8. PubMed ID: 10209056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
    Nakao M; Tada M; Tsuchimori K; Uekata M
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):391-9. PubMed ID: 7556227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine.
    Piotrowski J; Piotrowski E; Slomiany A; Slomiany BL
    J Physiol Pharmacol; 1995 Dec; 46(4):463-9. PubMed ID: 8770790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
    Nakao M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S32-7. PubMed ID: 7673612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
    Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro anti-Helicobacter pylori activity of ebrotidine.
    Palacín C; Tarragó C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):471-4. PubMed ID: 9205746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.
    Iwahi T; Satoh H; Nakao M; Iwasaki T; Yamazaki T; Kubo K; Tamura T; Imada A
    Antimicrob Agents Chemother; 1991 Mar; 35(3):490-6. PubMed ID: 2039199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
    Nakao M; Malfertheiner P
    Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
    Spadaccini A; De Fanis C; Sciampa G; Russo L; Silla M; Pantaleone U; Di Virgilio M; Pizzicanella G
    Aliment Pharmacol Ther; 1998 Oct; 12(10):997-1001. PubMed ID: 9798805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M; Székely E; Illyés G; Széles I
    Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates.
    López-Brea M; Domingo D; Sánchez I; Prieto N; Alarcón T
    J Antimicrob Chemother; 1998 Sep; 42(3):309-14. PubMed ID: 9786470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
    Midolo PD; Turnidge JD; Lambert JR; Bell JM
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1531-3. PubMed ID: 8726032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Helicobacter pylori urease activity by ebrotidine.
    Piotrowski J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1995 Oct; 37(2):247-53. PubMed ID: 8673007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.
    Alarcón T; Domingo D; Sánchez I; Díaz de Rojas F; López-Brea M
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):937-40. PubMed ID: 9031877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.
    Nagata K; Sone N; Tamura T
    Antimicrob Agents Chemother; 2001 May; 45(5):1522-7. PubMed ID: 11302821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.